Annual Report for the Financial Year Ended March 31,2026

Alpa Laboratories Ltd. 33/2, A.B. Road, Pigdamber-45 3446, Distt. Indore (M.P.) India Phone No.: +91-731-429 4567 Fax No.: +91-731-429 4444, E-mail: cs.alpalabs@gmail.com CIN-L85195MP1988PLC004446 Date: - 07th September, 2026 Listing Department, Listing Department, National Stock Exchange of India Limited. Bombay Stock Exchange Limited. ‘Exchange Plaza’, C-1, Block G, Rotunda Building, P J Towers, Bandra - Kurla Complex, Dalal Street, Fort, Bandra (E), Mumbai - 400 051 Mumbai - 400 001 Scrip Code: ALPA Scrip Code: 532878 Subject: Notice of the 38th Annual General Meeting and the Annual Report FY 2025-26 as per Regulation 34 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Respected Sir/Madam, Pursuant to Regulation 34 of SEBI (LODR) Regulations, 2015, please find enclosed the Notice convening the 38th Annual General Meeting (AGM) of shareholders and the Annual Report for the financial year 2025-26 which is being circulated to the shareholders through electronic mode for the AGM to be held on Wednesday, 30th September, 2026 through video conference (VC). The Notice and the annual report will also be made available on the Company’s website at www.alpalabs.in Kindly take the above information on record. Thanking you, Yours faithfully, FOR ALPA LABORATORIES LIMITED Digitally signed by Mahendra Singh Chawla DN: c=IN, o=Personal, Mahendra Singh Chawla 2.5.4.20=76bc09205476137a1eb156ed15fc708d04ac4cbc7efabee2426446d34641e695, postalCode=452020, l=Indore, st=Madhya Pradesh, serialNumber=ec95108145a2aca865b24a396b3325d9ded484fd9783edf50daaad61264c83d3, email=3pitg8x9dp@zvvzuv.com, cn=Mahendra Singh Chawla Date: 2026.09.07 18:14:33 +05'30' Mahendra Singh Chawla Director ALPA LABORATORIES LIMITED Alpa Laboratories Limited — Annual Report FY 2025-26 | Page 1 WELCOME Alpa Laboratories Limited — Annual Report FY 2025-26 | Page 2 CONTENT • Report on Corporate Governance……………………………….……..…..28 • Management Discussion and Analysis…………………………………….60 • Standalone Financial Statements…………………………….……...…….73 • Consolidated Auditor’s Report…………………………………………..107 • Consolidated Financial Statements…………………………...……….…113 Alpa Laboratories Limited — Annual Report FY 2025-26 | Page 3 Corporate Information Board of Directors 1. Mahendra Singh Chawla – Chairman 2. Paresh Chawla- Managing Director Chief Financial Officer 3. Pravin Shah – Director Bakulesh Shah 4. Shitul Shah- Director 5. Vitthal Kothana- Director 6. Sunil Kumar Valecha- Independent Director Company Secretary 7. Sanket Baheti- Independent Director Srashti Chopra ** 8. Pratibha Lunawat- Independent Director Yashoda Patidar *** 9. Jyoti Jain- Independent Director * 10. Pratik Shah- Independent Director Audit Committee 1. Sunil Kumar Valecha - Chairperson 2. Pratibha Lunawat – Member 3. Mahendra Singh Chawla – Member Nomination and Remuneration Committee 1. Sanket Baheti - Chairperson 2. Jyoti Jain – Member 3. Sunil Kumar Valecha - Member Stakeholder Relationship Committee 1. Sunil Kumar Valecha – Chairperson 2. Jyoti Jain – Member 3. Mahendra Singh Chawla – Member Corporate Social Responsibility Committee 1. Pravin Shah – Chairperson 2. Sunil Kumar Valecha - Member 3. Pratibha Lunawat – Member Cost Auditors Registered Office M/s Sudeep Saxena & Associates 33/2, A.B Road, Pigdamber, Rau Indore-453446, Madhya Pradesh, India Secretarial Auditors Phone: 0731-4294567 M/s Shilpesh Dalal & Co., Company Secretaries Fax: 0731-4294444 Statutory Auditors M/s CH Padliya & Co, Chartered Accountants Investor Services Email ID cs@alpalabs.in Registrar and Transfer Agent Bigshare Services Private Limited Office No S6-2, 6th Floor, Pinnacle Website Business Park Next to Ahura Centre www.alpalabs.in Mahakali Caves Road, Andheri (East) Mumbai-400093, Maharashtra Phone No: 022-62638200 Fax: 022-62638299 * Ceased with effect from 21st July 2026. ** Resigned with effect from 25th March 2026. *** Appointed with effect from 11th April 2026 and Resigned with effect from 26th July 2026. Alpa Laboratories Limited — Annual Report FY 2025-26 | Page 4 NOTICE TO SHAREHOLDERS Notice is hereby given that the 38th Annual General Meeting of Alpa Laboratories Limited will be held on Wednesday, 30th Day of September 2026 at 14: 00 PM through Video Conferencing (“VC”) / Other Audio- Visual Means (“OAVM”) to transact the following business: ORDINARY BUSINESS 1. To receive, consider and adopt the Audited Standalone Financial Statement for the financial year ended March 31, 2026 and Reports of the Board of Directors and the Auditors thereon. 2. To receive, consider and adopt the Audited Consolidated Financial Statement for the financial year ended March 31, 2026 and Reports of the Board of Directors and the Auditors thereon. 3. To appoint a director in place of Mr. Mahendra Singh Chawla (DIN: 00362058), who retires by rotation and being eligible, offers himself for re-appointment. SPECIAL BUSINESS 4. To consider and if thought fit, to pass the following resolution as Ordinary Resolution: RATIFICATION OF REMUNERATION OF COST AUDITORS OF THE COMPANY FOR THE YEAR 2026-27 “RESOLVED THAT pursuant to the provisions of Section 148 (3) and other applicable provisions of the Companies Act, 2013, and Companies (Audit and Auditors) Rules, 2014 including any statutory modification or re-enactments thereof, M/s Sudeep Saxena and Associates, Cost Accountants, Indore (Firm Reg No. 100980), be and are hereby confirmed as Cost Auditor of the Company, as appointed by the Board of Directors of the Company, to conduct the audit of the cost records of the Company, as applicable, for the financial year ending as on 31st March, 2027, be confirmed and be paid remuneration of Rs. 70,000 per year plus reimbursement of out-of-pocket expenses.” 5. To consider and if thought fit, to pass the following resolution as Ordinary Resolution: APPOINTMENT OF MRS. RADHIKA BIYANI AS AN INDEPENDENT DIRECTOR OF THE COMPANY “RESOLVED THAT pursuant to the provisions of Section 149, 152 and other applicable provisions, if any, of the Companies Act, 2013 and the Companies (Appointment and Qualifications of Directors) Rules, 2014 and the applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, including any statutory modification(s) or re-enactment(s) thereof, for the time being in force, Mrs. Radhika Biyani (DIN:11918173), who has been appointed as an Additional Independent Director with effect from August 13, 2026, by the Board of Directors based on the recommendation of the Nomination and Remuneration Committee, be and is hereby appointed as an Independent Director of the Company for a term of 5 (five) years commencing from 30th September , 2026 to 30th September, 2031, who shall not be liable to retire by rotation. RESOLVED FURTHER THAT any of the Director of the Company be and are hereby severally authorised to do all such acts, deeds, matters and things as are necessary to give effect to this resolution.” Alpa Laboratories Limited — Annual Report FY 2025-26 | Page 5 6. To consider and if thought fit, to pass the following resolution a Special Resolution: “RESOLVED THAT pursuant to the provisions of the Section 186 and other applicable provisions, if any, of the Companies Act, 2013, consent of the Company be and is hereby accorded to the Board of Directors of the Company (hereinafter called ‘the Board’ which term shall deemed to include any Committee which Board may have constituted or hereinafter constitute to exercise its powers including the powers conferred by this resolution) to (a) give any loan to any person or other body corporate; (b) give any guarantee or provide security in connection with a loan to any other body corporate or person; and (c) acquire by way of subscription, purchase or otherwise the securities of any other body corporate, upto a maximum aggregate amount of Rs.160 crores, outstanding at any point of time, over and above the permissible limits under Section 186(2) of the Companies Act, 2013 [Showing first 8,000 characters — download PDF for full document]